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SUMMARY. The subcellular distribution of cardiac muscarinic receptors was defined in canine ventricular myocardium, and receptors were solubilized from subcellular fractions enriched in muscarinic receptor content. The subcellular location of muscarinic receptors in cardiac tissue was determined by measurement of the distribution of -ATPase throughout the subcellular fractions, muscarinic receptors appeared to be localized to sarcolemma in canine ventricular myocardium. Therefore, membrane fractions enriched in sarcolemma were used as a source of cardiac muscarinic receptors for solubilization. Treatment of membrane vesicle fractions with digitonin (0.6%) resulted in solubilization of [ 3 H](±)quinuclidinyl benzilate-binding activity with an extraction yield of 25-35%. Criteria of pharmacological specificity and stereospecificity established the identity of the solubilized binding activity of muscarinic receptors. Solubilization of muscarinic receptors was documented by demonstration of hydrodynamic behavior consistent with molecularly dispersed material. Upon glycerol gradient centrifugation, digitonin-solubilized muscarinic receptors from cardiac tissue sedimented with an apparent sedimentation coefficient of 9S. Pharmacological characterization of the digitonin-solubilized receptors revealed 8-to 39-fold reductions in affinities for muscarinic antagonists compared to the affinities exhibited by receptors in the membrane-bound state. Substantially greater reductions in agonist affinities (reduction of at least 700-fold for all agonists studied) suggested selective loss of ability of the digitonin-solubilized receptors to exhibit high affinity agonist interactions. In contrast to membrane-bound receptors, digitonin-solubilized receptors also demonstrated a loss of guanine nucleotide regulation, as well as steep agonist:radioligand competition curves with slope factors of 1.0, suggesting a homogeneous population of agonist-binding sites. Interpreted within the context of a model of state interconversion for merrbrane-bound receptors, the results suggested that either muscarinic receptors of a single state were selectively solubilized, or that solubilization induced conversion of all receptors to a single low affinity state, possibly by removal of constituents necessary for assumption of a high affinity agonist conformation. (Fields et al., 1978; Wei and Sulakhe, 1978; Mirro et al., 1980) . The role of these muscarinic receptors in the modulation of biochemical and electrophysiological events at the cellular level remains a subject of considerable interest. Development of techniques for solubilization and subsequent reconstirution of nicotinic acetylcholine receptors into artificial membrane systems has led to improved understanding of the structure and function of these receptors at a molecular level (see Anholt, 1981 , for recent review). Parallel efforts toward solubilization and reconstitution of muscarinic acetylcholine receptors have lagged behind, partially because of the absence of extremely rich sources of muscarinic receptors comparable to those available for the study of nicotinic receptors (electric organs of Electrophorus and Torpe cies). Using mammalian brain as a receptor several investigators have reported solubiliz; muscarinic receptors using aqueous solution: plant glycoside digitonin (Beld and Alien: Aronstam et al., 1978; Gorissen et al., 1978; 1978; Gorissen et al., 1981) . Only recently, C al. (1981) described the first solubilization of rinic receptors from cardiac tissue. However, atively low density of muscarinic receptors pr the original porcine atrial membrane source (r values 300-500 fmol [ 3 H]QNB binding sites/i tein) limited the quantity of cardiac muscarinii tors obtained upon solubilization (Cremo et al Techniques for the preparation of highly e preparations of sarcolemma and sarcoplasmic lum from canine ventricular myocardium ha viously been developed in our laboratory Qom 1979 Qom , 1980 Jones and Cala, 1981) . In the study, the membrane distribution of muscarinic receptors has been examined using these well-characterized membrane fractions. Based upon present results, muscarinic receptors appear to be localized to sarcolemma in canine ventricular myocardium. Therefore, sarcolemmal-enriched fractions have been employed as sources of cardiac muscarinic receptors for solubilization. Use of these enriched sources of cardiac muscarinic receptors for the preparation of solubilized receptors has afforded the opportunity to characterize both physical and pharmacological properties of digitonin-solubilized muscarinic receptors.
Methods

Preparation of Cardiac Membrane Vesicles
The two procedures used to prepare crude cardiac membrane vesicles selectively enriched in sarcoplasmic reticulum (procedure I) or sarcolemma (procedure II) are described in detail by Jones et al. (1979) . Briefly, Procedure II differed from procedure I essentially in that several brief homogenization steps were first used to fragment selectively sarcoplasmic reticulum vesicles. Following consecutive low speed centrifugations, supernatant containing the sarcoplasmic reticulum vesicles was removed. Subsequent vigorous homogenization of particulate residue was used to generate membrane vesicles enriched in sarcolemma.
Ca ++ loading and sucrose gradient centrifugation of cardiac membrane vesicles prepared by procedure I were performed as recently described 0ones and Cala, 1981). To facilitate separation of vesicles derived from sarcoplasmic reticulum from those derived from sarcolemma, procedure I membrane vesicles were incubated in the presence of ATP, Ca ++ , and oxalate to increase selectively the density of sarcoplasmic reticulum vesicles. The calcium-loaded vesicles suspended in 0.25 M sucrose were layered over a discontinuous sucrose gradient consisting of consecutive layers of 0.6 M, 0.8 M, 1.0 M, and 1.5 M sucrose. Centrifugation was performed for 120 minutes at 27,000 rpm in an SW27 rotor (Beckman Instruments). Fraction A was collected at 0.25 M:0.6 M interface, fraction B at the 0.6 M:0.8 M interface, fraction C at the 0.8 M:1.0 M interface, fraction D at the 1.0:1.5 M interface and fraction E was the pellet that sedimented through 1.5 M sucrose. Highly purified sarcolemma was isolated from procedure II vesicles as recently described (Jones et al., 1980; Manalan and Jones, 1982) . Based on analysis of marker enzymes, the highly enriched sarcolemmal vesicles contained less than 5% contamination by sarcoplasmic reticulum (Jones et al., 1980; Manalan and Jones, 1982) . AH membrane vesicle fractions were suspended in 0.25 M sucrose, 30 IIIM histidine and stored frozen at -20°C until use.
ATPase Assays Na + ,K + -ATPase activities were measured as previously described (Jones et al., 1977) . To reveal total Na + ,K + -ATPase activity, membrane vesicle preparations (0.4-0.8 mg/ ml) were preincubated with sodium dodecyl sulfate at the optimal concentration of 0.3 mg/ml. Na + ,K + -ATPase activity then was assessed in a medium containing 15-25 /ig/ml of membrane protein, 50 ITIM histidine, 3mM MgCU, 1 nw Tris/EGTA, 100 ITIH NaCl, 10 mti KC1, and 3 nun Tris/ ATP, pH 7.4. Na + ,K + -ATPase activity was taken as that activity inhibitable by 1 mM ouabain. Ca ++ -ATPase activity was determined in a medium containing 15-25 jug/ml of membrane protein, 50 miu histidine, 3 mM MgCl2, 100 mM KC1, 50 /IM CaCl 2 , and 3 mM Tris/ ATP, pH 7.4 (Jones et al., 1977) . Ca ++ -ATPase activity was taken as that activity inhibitable by 1 mM Tris/EGTA. In all assays of Ca ++ -ATPase, the divalent cation ionophore A23187 (3 jig/ml) was included in the medium to eliminate calcium accumulation spaces (Jones et al., 1977) . (Yamamura and Snyder, 1974; Fields et al., 1978; Mirro et al., 1980) . Membrane vesicles (5-50 /tg protein) were incubated in 1 or 5 ml of medium containing either 50 mM Tris (pH 7.5 at 25°C) or 50 mM sodium phosphate buffer, pH 7.4, indicated concentrations of [ 3 H]1-QNB, guanine nucleotides, and relevant drugs. Dithiothreitol (0.1 mM), PMSF (0.1 mM), and leupeptin (10 /UM) were without effect on binding parameters in the membrane system and were therefore omitted from the assay mixtures. Incubations were conducted at 37°C for 60 minutes, a time which allowed complete equilibration of [ 3 H]1-QNB binding. Incubations were terminated by rapid filtration through Whatman GF/ C filters. Alternatively, following the 60-minute incubations, tubes were placed on ice prior to filtration to provide a control for comparison with results for solubilized receptors (see below). Identical results were obtained with either method. Filters were rinsed with four 5-ml aliquots of ice cold incubation buffer, air dried, and suspended in 10 ml Aquasol. Retained radioactivity was determined by liquid scintillation counting. All determinations of total and nonspecific binding were performed in triplicate. Specific binding was taken as that binding which was inhibited by 1 /tM atropine.
Muscarinic Receptor Solubilization
The solubilization procedure was performed by modification of the method described by Hurko (1978) for solubilization of muscarinic receptors from brain. All procedures were performed at 4°C. Membrane vesicles (approximately 3 mg protein) were suspended in 8 ml of buffer A, consisting of 150 mM sodium phosphate, pH 7.4, 0.1 mM dithiothreitol, 0.1 mM PMSF, and 10 (IM leupeptin, and centrifuged at 33,000 g for 30 minutes. The supernatant was discarded and the pellet resuspended in 1.5 ml of identical buffer containing 0.6% digitonin. This suspension was incubated for 30 minutes at 4°C with occasional stirring and then subjected to centrifugation at 82,000 g for 60 minutes to sediment residual unsolubilized material. The supernatant containing solubilized receptors was collected, and assayed for protein. The supernatant was diluted accordingly in the above-described buffers to achieve a protein concentration of 0.75 mg/ml and a final digitonin concentration of 0.3%. All preparations of solubilized receptors were used immediately. Recovery of solubilized muscarinic receptors, assessed by the [ 3 H]1-QNB charcoal adsorption assay, was in the range of 25% to 35%.
Protein Determinations
All protein determinations used in the analysis of receptor solubilization were performed utilizing Coomassie brilliant blue as described by Bradford (1976) . Protein determinations during the course of preparation and characterization of the membrane vesicle fractions were performed by the method of Lowry et al. (1951) . As previously noted (Hurko, 1978; Gorissen et al., 1981) , the presence of digitonin affects results of both of these protein assays. In the case of the assay of protein using Coomassie blue (Bradford, 1976) , the presence of digitonin results in a systematic overestimation of the protein present (Gorissen et al., 1981) . Similarly, in the present study, inclusion of digitonin in protein standards used for calibration curves did not completely correct for digitonin effects on protein assays in the membrane system, as reflected by protein recoveries in excess of 100% as a result of treatment of membranes with digitonin. In the absence of a completely satisfactory method of correction, protein determinations have been calibrated against a standard curve performed in the presence of digitonin, and results were used without additional correction in the calculation of receptor concentrations. Following incubation, tubes were placed on ice, 0.5 ml of a cold (4°Q 10% suspension of activated charcoal containing 4% bovine serum albumin was added, and the resulting mixtures vigorously agitated. Mixtures containing activated charcoal were subsequently incubated for exactly 20 minutes on ice prior to centrifugation for 5 minutes at 4°C in a Beckman microfuge model B. A 0.6-ml aliquot of supernatant was removed from each tube, suspended in 10 ml of Aquasol, and radioactivity determined with a Beckman liquid scintillation counter (counting efficiency 56%). All determinations of total and nonspecific binding were performed in duplicate. Specific binding was taken as that binding which was displaceable by 10 /JM atropine. The concentration of solubilized muscarinic receptors in the incubations was in the range of 30-60 pM, a concentration which minimized changes in free radioligand concentration during the course of the binding reaction. Even at the low receptor concentrations used, specific [ 3 H]1-QNB binding was linearly related to protein concentration over the entire range of protein concentrations encountered in the present study.
Millipore Filtration
To document solubilization of muscarinic receptors, aliquots of digitonin extracts were incubated at 37°C for 60 minutes in 0.4 ml of buffer A, 0.03% digitonin, 1 nM [ 3 H]1-QNB, in the absence or presence of 10~5 M atropine. Following incubation, tubes were placed on ice. Aliquots of 0.2 ml were suspended in 5 ml of ice cold buffer A containing 0.03% digitonin and rapidly filtered through Millipore 0.22-/jjn filters. Filters were rinsed with three 5-ml aliquots of identical buffer, dried, and retained radioactivity determined by liquid scintillation counting. The [ 3 H]1-QNB charcoal adsorption assay was conducted on duplicate incubation mixtures to allow comparison of binding activity in the digitonin extracts with that retained by the 0.22-ftm Millipore filters.
Gel Filtration
Solubilization of muscarinic receptors was established by gel filtration of digitonin-extracted material on Sepharose 4B-CL. Sarcolemmal enriched membrane vesicles (SL, 1.3 mg protein) were sedimented in a total volume of 300 /il of medium containing 50 ITIM sodium phosphate, pH 7.4,0.125 M sucrose, and 15 nw histidine by centrifugation at 33,000 g for 30 minutes at 4°C. Supernatant was removed, and pelleted material resuspended in 200 fi\ of buffer A with 0.6% digitonin. Solubilization was conducted as described, except that the resultant supernatant was not diluted further prior to loading onto the column. The digitonin-solubilized material (200 /d) was applied to a 0.5 X 20 cm column of Sepharose 4B-CL equilibrated at 4°C with buffer A with 0.03% digitonin. The column was eluted with identical buffer at a flow rate of 2 ml/hour, collecting fractions of 80-100 /il dropwise. Aliquots were taken for protein determination. Every three consecutive fractions were pooled and assayed for soluble muscarinic receptor content using the charcoal adsorption assay. 
Glycerol Gradient Centrifugation
Highly enriched preparations of sarcolemmal vesicles (SL) were used as a source of muscarinic receptors for centrifugation in the glycerol gradients. Muscarinic receptors were radiolabeled prior to solubilization, a modification which facilitated removal of the bulk of free [ calibration standards. Aliquots (100/il) of each fraction were suspended in 10 ml Aquasol for quantitation of [ 3 H]1-QNB by liquid scintillation counting. The glycerol gradient centrifugations were quite reproducible, as determined by internal and external standardization. Accordingly, specific [ 3 H]1-QNB binding to solubilized receptors was taken as the difference between counts present in corresponding gradient fractions prepared from material labeled in the absence and presence of 10 JUM atropine.
Analysis of Data
Data from radioligand competition curves were subjected to mathematical transformation to obtain linearized plots of log [RQ/fRQma* -RQ)] vs. log A, where RQ™ is the amount of [ 3 H]QNB bound specifically in the absence of competing drug, RQ is the specific [ 3 H]QNB binding in the presence of competing drug, and A is the concentration of competing drug. Linear regression analysis of these derived data provided values for the slope factor ("pseudo-Hill coefficient") and x-intercept [equivalent to log (ICso)]. Ki for competing drug was then calculated from the IC50 by the method of Cheng and Prusoff (1973) . Guanine nucleotideinduced changes in Ki for competing muscarinic agonists were analyzed for statistical significance by use of paired ttests of Ki's derived from paired competition curves generated in the absence or presence of added guanine nucleotides. 
Materials
Results
Subcellular Distribution of Cardiac Muscarinic Receptors
Selection of a suitable membrane source from which to prepare solubilized cardiac muscarinic receptors was facilitated by the examination of the distribution of muscarinic receptors in subcellular fractions from canine ventricular myocardium. Initially, muscarinic receptor distribution was examined in subcellular fractions prepared by differential centrifugation of a crude ventricular homogenate (procedure I). Na H](±)QNB-binding activity in this centrifugation procedure suggested a common membrane location of these activities. However, because the resultant membrane vesicle fraction contained significant quantities of partially purified sarcoplasmic reticulum, as well as sarcolemma, the possibility that a significant population of muscarinic receptors resided in membranes other than sarcolemma was not excluded by this analysis alone.
Discontinuous sucrose density gradient centrifugation of calcium-loaded crude membrane vesicles was employed to separate subpopulations relatively enriched in sarcolemma from subpopulations enriched in sarcoplasmic reticulum (Jones et al., 1981) . After sucrose density gradient centrifugation, five subfractions (A-E) were isolated. Ca ++ -ATPase activity, unmasked by the ionophore A23187, was used as a marker of sarcoplasmic reticulum content. Partial separation of the membranes derived from sarcolemma from those derived from sarcoplasmic reticulum was confirmed by analysis of unmasked ATPase activities (Fig. 1) . The activity of the sarcolemmal marker Na To obtain a membrane fraction containing the highest possible muscarinic receptor content, a highly enriched preparation of sarcolemmal vesicles was isolated by sucrose density gradient centrifugation of cardiac membrane vesicles obtained by procedure II, as recently described (Jones et al., 1980; Manaian and Jones, 1982) . Based on analysis of unmasked ATPase activities (Na (Fig.  2) , muscarinic receptors appeared to be localized to sarcolemma in canine ventricular myocardium. In addition, demonstration of a negative correlation of binding activity with the activity of Ca ++ -ATPasedissociated [ 3 H](±)QNB binding from a location in sarcoplasmic reticulum (Fig. 1) .
Throughout the fractionation process, the binding properties of the muscarinic receptors were quantitatively preserved (data not shown). The muscarinic receptor population remained saturable, without alteration in affinity for [ 3 H](±)QNB or a series of unlabeled muscarinic agents. Preservation of the stereospecificity of interaction of the stereoisomers of benzetimide with muscarinic receptors was also demonstrated.
Solubilization of Cardiac Muscarinic Receptors
Muscarinic receptors were solubilized by incubation of cardiac membrane vesicle preparations with 0.6% digitonin. Application of this technique to solubilization of muscarinic receptors using crude cardiac membrane vesicles (procedure I) as a receptor source produced solubilized receptors in sufficient concentration to allow pharmacological characterization. The sarcolemma-enriched membrane vesicles (SL) were used as a receptor source for gel filtration and sedimentation studies allowing the application of receptors in a minimal volume. For both membrane vesicle preparations, recovery of solubilized receptors, as assessed by the charcoal adsorption assay, was in the range of 25-35%, comparable to that reported by Hurko for digitonin solubilization of receptors from brain homogenates (1978) .
Four different solubilization criteria were examined in order to document that muscarinic receptors were being studied in a solubilized state. First, the binding activity present in digitonin extracts prepared by this method remained in the supernatant fraction following recentrifugation at 105,000 g for 90 minutes, consistent with solubilization of receptors. Second, unlike binding activity present in the membrane vesicles, [ 3 H]1-QNB binding activity present in the digitonin extracts passed through 0.22-fim Millipore filters, providing further evidence of solubilization. Third, enriched preparations of digitonin-solubilized receptors derived from the SL fraction were subjected to gel filtration on Sepharose 4B-CL under conditions identical to that present in the charcoal adsorption assay (Fig. 3) (Fig. 4) . Based upon comparison with sedimentation of internal and external standards, a sedimentation coefficient for the muscarinic receptor-digitonin complex of approximately 9S was obtained (Fig. 4, inset) .
Characterization of Digitonin-Solubilized Cardiac Muscarinic Receptors
Assay of solubilized muscarinic receptors was performed using a [ (Fig. 5A ) and digitonin-solubilized receptors (Fig. 5B) ELUTION VOLUME (ml) FIGURE 3. Gel filtration of digitonin-solubilized cardiac muscarinic receptors on Sepharose 4B-CL. Chromatography was performed as described in Methods. Elution of cardiac muscarinic receptors solubilized from highly enriched sarcolemmai vesicles (A) was determined by assaying column fractions using the [ 33-fold reduction in receptor affinity for [ 3 H]1-QNB when compared with that exhibited by the muscarinic receptors in their membrane-bound state (KD 2.3 X 10~n M). Similar results were obtained in assays conducted in the presence of a 20-fold higher concentration of digitonin (0.6%), suggesting that the observed reductions in affinity were not the result of a simple competition between digitonin and radioligand for binding to the solubilized receptors. The lowered affinity of solubilized receptors for QNB was corroborated by comparison of unlabeled (±)QNB: [ 3 H]1-QNB competition curves generated using membranebound and digitonin-solubilized receptors (Fig. 6) . Inhibition constants (Ki) for (±)QNB competition curves documented a quantitatively similar 39-fold reduction in affinity of the digitonin-solubilized receptors for (±)QNB (Table 1) . For muscarinic receptors, both in membrane-bound and solubilized form, values of inhibition constants for (±)QNB were approximately twice that of the corresponding dissociation constants for [ present prior to and throughout the solubilization process, or added only to the final assay reaction, exhibited no effect on either the position or configuration of agonist competition curves for the solubilized receptors (Fig. 7B, Table 1 ).
Discussion
Muscarinic receptor content was determined in a series of subcellular fractions prepared from canine ventricular myocardium by a combination of differential centrifugation, calcium loading, and discontinuous sucrose gradient sedimentation. Based upon positive correlation between [ 3 H](±)QNB binding and the activity of the sarcolemmal Na + ,K + -ATPase, muscarinic receptors appeared to be localized to sarcolemma in canine ventricular myocardium. Accordingly, membrane vesicle fractions demonstrating enrichment of sarcolemmal activities were used as enriched sources of cardiac muscarinic receptors to facilitate solubilization and characterization.
Cardiac muscarinic receptors were solubilized from sarcolemmal-enriched canine ventricular membrane vesicle preparations using aqueous solutions of 0.6% digitonin. Development of a [ , and approximately 1000 pin for curves generated for solubilized preparations (panel B). Slope factors and inhibition constants derived from competition curves are presented in Table 1. havior must also be considered in interpretation of the data.
In designing a suitable assay for solubilized preparations of muscarinic receptors, the problem of separation of bound radioligand from free radioligand has been approached previously in a variety of ways, including spotting on DEAE-cellulose discs, ammonium sulfate precipitation, polyethylene glycol 6000 precipitation, Sephadex G-50 gel exclusion, and charcoal adsorption, as well as equilibrium dialysis (Beld and Ariens, 1975; Aronstam et al., 1978; Gorissen et al., 1978; Hurko, 1978; Gorissen et al., 1981; Cremo et al., 1981) . Recently, a rapid charcoal adsorption assay using [ 3 H]dexetimide has been developed, characterized, and shown to give results quantitatively identical to those obtained using the Sephadex G-50 assay method in the study of digitonin-solubilized muscarinic receptors (Gorissen et al., 1981) . In the present study, the charcoal adsorption method was applied in the development of an assay for solubilized receptors using the high affinity muscarinic antagonist [ 3 H]1-QNB. The result was a rapid, efficient assay method which has proven to be well suited to the study of digitonin-solubilized muscarinic receptors derived from cardiac tissue.
To provide functional assessment of the solubilized muscarinic receptors, equilibrium binding characteristics of digitonin-solublized receptors were compared quantitatively with those present in cardiac membrane vesicles. Results obtained for membrane-bound canine cardiac muscarinic reepceptors demonstrated excellent agreement with those reported for rabbit heart homogenates (Fields et al., 1978) . Analysis of [ 
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Cardiac membrane vesicles prepared by procedure I were used as a source of muscarinic receptors. Parameters derived from [ HJl-QNB competition curves (see Methods) are presented as a mean ± SEM for the number of experiments shown in parentheses. For some agents, results are means of duplicate experiments, expressed as a mean ± SD. P values are results of paired t-tests of inhibition constants derived for paired agonist:radioligand competition curves generated in the absence and presence of 0.1 mM GTP. Addition of guanine nucleotides had no effect on the position or configuration of competition curves for muscarinic antagonists (data not shown). The affinity ratio for each agent is the quotient of the inhibition constant for solubilized receptors divided by the inhibition constant for membrane-bound receptors. For both carbamylcholine and methacholine competition curves, ICso's greater than 10~3 M precluded reliable quantitative analysis of affinities for the digitonin-solubilized receptors.
sociation constant 23 ± 2 pM quite similar in magnitude to the value of 27 pM for [ 3 H](±)QNB reported by Fields et al. (1978) . Based upon comparison of binding characteristics, digitonin-solubilized muscarinic receptors demonstrated a reduction in affinities for muscarinic antagonists. For example, the dissociation constant for [ (Hurko, 1978) , as well as to that of 860 ± 120 pM reported from a single experiment utilizing a digitonin-solubilized preparation derived from porcine heart (Cremo et al., 1981) . Systematic comparison of antagonist:[ 3 H]l-QNB competition curves for a series of muscarinic antagonists revealed 8-to 39-fold reductions in antagonist affinities exhibited by cardiac muscarinic receptors in the digitonin-solubilized state. These observed reductions in antagonist affinity presumably reflected alterations attendant to disruption of the lipid environment of the membrane-bound receptors with replacement by molecules of digitonin.
Interactions of muscarinic receptors with agonists were similarly examined in the membrane-bound and digitonin-solubilized preparations. Muscarinic agonist:radioligand competition curves generated for membrane-bound receptors were shallow in contour, with slope factors ("pseudo Hill coefficients") substantially less than one. In agreement with other studies (Berrie et al., 1979; Rosenberger et al., 1979) , addition of 0.1 mM GTP induced a significant rightward shift in the position of radioligand competition curves for all agonists studied. These guanine nucleotide-induced alterations in agonist affinities were detectable in the various sarcolemmal-enriched fractions, which have been shown to consist of membrane vesicles existing predominantly in a functionally sealed, right-side-out orientation 0ones et Manalan and Jones, 1982) . Consequently, the observed magnitude of the guanine nucleotide effects may have been limited as a result of incomplete access of exogenous nucleotides to regulatory sites in the vesicular preparations used. Indeed, using crude homogenates of canine ventricular myocardium, we have documented up to 30-fold reductions of receptor affinity for oxotremorine induced by guanine nucleotides (unpublished observation).
Interactions of agonists with muscarinic receptors were profoundly altered upon receptor solubilization , and approximately 1000 pin for curves generated in the solubilized preparation (panel B). For each experiment, agonist.radioligand competition curves were generated both in the absence (O) and presence (•) of 10 ~4 M GTP in the assay medium. Slope factors and inhibition constants derived from agonist.radioligand competition curves are presented in Table 1. with digitonin. Comparison of agonistradioligand curves revealed at least 700-fold reductions in agonist affinities for solubilized receptors. Notably, the magnitude of these reductions in agonist affinities was far greater than that observed for antagonists. Agonistradioligand competition curves generated for solubilized cardiac muscarinic receptors exhibited steep contours, with slope factors of approximately 1.0. Furthermore, guanine nucleotide effects on agonist affinities were not demonstrable with digitonin-solubilized receptors. Thus, characteristic properties of agonist interaction with membrane-bound muscarinic receptors, including relatively high affinity, kinetic complexity manifested by slope factors less than 1, and regulation by guanine nucleotides were lost upon receptor solubilization in digitonin. Taken together, these observations suggested the presence of agonistselective alterations in the behavior of muscarinic receptors following solubilization in digitonin.
Based upon quantitative analysis of the shallow agonist-binding curves exhibited by muscarinic receptors from brain, Birdsall et al. (1980a) have proposed that muscarinic receptors exist in three different interconvertible states, exhibiting different affinities for agonists. On the basis of agonist affinities, these receptor states have been termed super-high (SH), high (H), and low (L) affinity (Birdsall et al., 1980a) . Within the context of this model, guanine nucleotides have been interpreted to induce a change in receptor state from H to L (Birdsall et al., 1980a) . Such transitions have been proposed to reflect conformational changes attendant to receptor effector coupling (Birdsall et al., 1980a) . The molecular mechanisms accounting for the interconversions between these states have not been established, but interactions involving either membrane "matrix elements" or specific receptorassociated subunits have been proposed to account for the experimental results (Birdsall et al., 1980b) . In this regard, it is tempting to suggest possible analogy with the /?-adrenergic receptor system, in which guanine nucleotide interaction with a membrane-associated nucleotide-binding protein appears to result in dissociation of this protein from the /?-adrenergic receptor, with attendant conversion of the dissociation receptor to a state of low agonist affinity (Limbird et al., 1980; DeLean et al., 1980; Stadel et al., 1980) . Thus, the characteristic shallow agonist radioligand competition curves have been interpreted to reflect the complex regulation of receptor units, subject to conformational constraints imposed by additional interacting membrane constituents.
In the present study, alterations in the characteristics of receptor: agonist interaction were demonstrated for cardiac muscarinic receptors subjected to solubilization in digitonin. In contrast to membrane-bound receptors, solubilized receptors exhibited reductions in agonist affinities, loss of guanine nucleotide regulation, and steep agonist:radioligand competition curves with slope factors of 1.0, suggesting a homogeneous population of agonist-binding sites. Based upon the model of state interconversion for membrane-bound receptors, present results suggested either that muscarinic receptors of a single state were selectively solubilized, or that solubilization induced conversion of all receptors to a single low affinity state, possibly by removal of constituents necessary for assumption of a high-affinity agonist conformation. In either case, the subpopulation of muscarinic receptors solubilized fails to exhibit alterations in agonist affinities in response to guanine nucleotides, a phenomenon that has been thought to reflect consequences of receptoneffector coupling. It is possible that this functional deficiency results from the absence of essential molecular constituents in the digitonin-solubilized complex. Alternatively, required Physiologically, cholinergic stimulation of ventricular myocardium has been shown to exert a negative inotropic effect, which is accentuated by the presence of concomitant adrenergic stimulation (for review, see Levy, 1971) . At the biochemical level, muscarinic agonists attenuate both GTP and isoproterenol-stimulated adenylate cyclase in membrane fractions derived from ventricular myocardium . Recently, all of the individual components of a catecholamine responsive complex (/?-adrenergic receptors, adenylate cyclase, cAMP-dependent protein kinase) have been identified in highly purified preparations of sarcolemma (Jones et al., , 1980 Manalan and Jones, 1982) . The present results document a sarcolemmal location for muscarinic receptors as well. Thus, it seems possible that muscarinic modulation of the adenylate cyclase complex is mechanistically confined to interactions which occur entirely within the sarcolemma. The solubilization of muscarinic receptors from canine ventricular myocardium provides a basis for reconstitution experiments directed toward understanding the molecular mechanisms accounting for muscarinic effects in cardiac tissue.
